AMC

FUJISAWA PHARMACEUTICAL CO -- GENTAMICIN SULFATE INJECTION -- 6505-01-091-2326
=====================  Product Identification  =====================

Product ID:GENTAMICIN SULFATE INJECTION
MSDS Date:01/01/1994
FSC:6505
NIIN:01-091-2326
MSDS Number: BQXWB
=== Responsible Party ===
Company Name:FUJISAWA PHARMACEUTICAL CO
Address:PARKWAY NORTH CENTER, 3 PARKWAY N
City:DEERFIELD
State:IL
ZIP:60015-2548
Country:US
Info Phone Num:708-317-0800
Emergency Phone Num:800-888-7704
Preparer's Name:CHRISTINA J. BARRINGTON
CAGE:EO410
=== Contractor Identification ===
Company Name:FUJISAWA PHARMACEUTICAL CO
Address:PARKWAY NORTH CENTER, 3 PARKWAY N
Box:City:DEERFIELD
State:IL
ZIP:60015-2548
Country:US
Phone:708-317-0800
CAGE:EO410
Company Name:FUJISAWA USA, INC
Address:3 PKY N
Box:City:DEERFIELD
State:IL
ZIP:60015-2548
Country:US
Phone:847-317-1256
CAGE:39832
Company Name:FUJISAWA USA, INC.
Address:3 PARKWAY NORTH
Box:City:DEERFIELD
State:IL
ZIP:60015-2548
Country:US
Phone:708-317-0800 OR 800-888-7704
CAGE:0K706

=============  Composition/Information on Ingredients  =============

Ingred Name:GENTAMICIN SULFATE
CAS:1405-41-0
RTECS #:LY2625000
Other REC Limits:NONE RECOMMENDED

Ingred Name:METHYLPARABEN (NOTE: PRODUCT NUMBER 17302 IS PRESERVATIVE
    FREE)
CAS:99-76-3
Other REC Limits:NONE RECOMMENDED

Ingred Name:PROPYLPARABEN (NOTE PRODUCT NUMBER 17302 IS PRESERVATIVE
    FREE)
CAS:94-13-3
Other REC Limits:NONE RECOMMENDED

Ingred Name:SODIUM BISULFITE  (SASA III)  (NOTE: PRODUCT NUMBER 17302
    IS PRESERVATIVE FREE)
CAS:7631-90-5
RTECS #:VZ2000000
Other REC Limits:NONE RECOMMENDED
OSHA PEL:5 MG/M3
ACGIH TLV:5 MG/M3; 9293
EPA Rpt Qty:5000 LBS
DOT Rpt Qty:5000 LBS

Ingred Name:DISODIUM EDETATE (NOTE: PRODUCT NUMBER 17302 IS
    PRESERVATIVE FREE)
CAS:6381-92-6
Other REC Limits:NONE RECOMMENDED

Ingred Name:WATER FOR INJECTION.  (NOTE: PH ADJUSTED WITH SODIUM
    HYDROXIDE AND/OR SULFURIC ACID IF NECESSARY)
CAS:7732-18-5
RTECS #:ZC0110000
Other REC Limits:NONE RECOMMENDED

=====================  Hazards Identification  =====================

LD50 LC50 Mixture:LD50: 108 MG/KG INTRAVENOUS RAT
Routes of Entry: Inhalation:YES  Skin:YES  Ingestion:YES
Reports of Carcinogenicity:NTP:NO    IARC:NO	OSHA:NO
Health Hazards Acute and Chronic:EYE, SKIN AND RESPIRATORY IRRITATION
    MAY OCCUR. DELAYED EFFECTS: HYPERSENSITIVITY REACTIONS RANGING FROM
    MILD TO SEVERE MAY OCCUR. NOTE: PRODUCT INTENDED FOR THERAPEUTIC
    USE ONLY WHEN PRESCRIBED BY A  PHYSICIAN.
Explanation of Carcinogenicity:THIS COMPOUND CONTAINS NO INGREDIENTS AT
    CONCENTRATIONS OF 0.1% OR GREATER THAT ARE CARCINOGENS OR SUSPECT
    CARCINOGENS.
Effects of Overexposure:EYE IRRITATION, SKIN IRRITATION, RESPIRATORY
    IRRITATION
Medical Cond Aggravated by Exposure:PRE-EXISITNG SKIN AND RESPIRATORY
    CONDITIONS MAY BE ADVERSELY AFFECTED BY EXPOSURE.

=======================  First Aid Measures  =======================

First Aid:INHALATION: MOVE PERSON TO FRESH AIR IMMEDIATELY. GIVE
    ARTIFICIAL RESPIRATION AND CPR IF REQUIRED. SEEK MEDICAL ATTENTION.
    INGESTION: FLUSH MOUTH WITH WATER IMMEDIATELY. SEEK MEDICAL
    ATTENTION. SKIN:  REMOVE CONTAMINATED CLOTHING IMMEDIATELY. FLUSH
    AREA WITH WATER. SEEK MEDICAL ATTENTION. EYES: IMMEDIATELY FLUSH
    WITH WATER FOR AT LEAST 15 MINUTES. SEEK MEDICAL ATTENTION.

=====================  Fire Fighting Measures  =====================

Flash Point:>200F,>93C
Lower Limits:NOT GIVEN
Upper Limits:NOT GIVEN
Extinguishing Media:WATER SPRAY, DRY CHEMICAL, CARBON DIOXIE OR FOAM AS
    APPRORPIATE
Fire Fighting Procedures:WEAR FIRE FIGHTING PROTECTIVE EQUIPMENT AND
    FULL FACE-PIECE SELF-CONTAINED BREATHING APPARATUS.
Unusual Fire/Explosion Hazard:WHEN HEATED TO DECOMPOSITION IT EMITS
    TOXIC FUMES.

==================  Accidental Release Measures  ==================

Spill Release Procedures:WEAR RECOMMENDED PERSONAL PROTECTIVE
    EQUIPMENT. USE ABSORBENT TOWELS OR BOOMS TO CLEAN-UP SPILL. WIPE
    SURFACES CLEAN AND WASH WITH SOAP AND WATER.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.

======================	Handling and Storage  ======================

Handling and Storage Precautions:WHEN HANDLING PHARMACEUTICAL PRODUCTS,
    AVOID ALL CONTACT AND INHALATION OF DUST, FUMES, MISTS AND/OR VAPOR
    ASSOCIATED WITH THE PRODUCT.
Other Precautions:FOR ADVERSE DRUG REACTION INFORMATION, CALL
    708-317-5937.

=============  Exposure Controls/Personal Protection  =============

Respiratory Protection:WITH SATISFACTORY VENTILATION, RESPIRATORY
    PROTECTION NOT USUALLY REQUIRED.
Ventilation:GENERAL ROOM VENTILATION IS USUALLY SATISFACTORY, USE LOCAL
    EXHAUST VENTIALTION WHEN NECESSARY.
Protective Gloves:DISPOSABLE LATEX
Eye Protection:SAFETY GLASSES OR GOGGLES
Other Protective Equipment:DISPOSABLE GARMENTS IF DIRECT SKIN CONTACT
    IS ANTICIPATED.
Work Hygienic Practices:WASH WITH SOAP AND WATER AFTER HANDLING PRODUCT
    AND BEFORE EATING DRINKING OR SMOKING.
Supplemental Safety and Health
POTENTIAL ADVERSE REACTIONS FROM PRESCRIBED DOSES AND OVERDOSES ARE
    DESCRIBED MORE FULLY IN THE PACKAGE INSERT. OCCUPATIONL EXPOSURE
    HAS NOT BEEN FULLY INVESTIGATED.

==================  Physical/Chemical Properties  ==================

HCC:C3
Boiling Pt:B.P. Text:NOT GIVEN
Melt/Freeze Pt:M.P/F.P Text:NOT GIVEN
Vapor Pres:NOT GIVEN
Vapor Density:NOT GIVEN
Spec Gravity:NOT GIVEN
pH:3-5.5
Evaporation Rate & Reference:NOT GIVEN
Solubility in Water:SOLUBLE
Appearance and Odor:CLEAR, COLORLESS, ODORLESS SOLUTION

=================  Stability and Reactivity Data  =================

Stability Indicator/Materials to Avoid:YES
NONE SPECIFIED BY MANUFACTURER.
Stability Condition to Avoid:NONE SPECIFIED BY MANUFACTURER.
Hazardous Decomposition Products:SMOKE AND TOXIC FUMES OF SOX.

====================  Disposal Considerations  ====================

Waste Disposal Methods:PREVENT WASTE FROM CONTAMINATING SURROUNDING
    ENVIRONMENT. DISCARD ANY PRODUCT, RESIDUE, DISPOSAL CONTAINER OR
    LINER IN ACCORDANCE WITH ALL FEDERAL, STATE AND LOCAL REGULATIONS.

 Disclaimer (provided with this information by the compiling agencies):
 This information is formulated for use by elements of the Department
 of Defense.  The United States of America in no manner whatsoever,
 expressly or implied, warrants this information to be accurate and
 disclaims all liability for its use.  Any person utilizing this
 document should seek competent professional advice to verify and
 assume responsibility for the suitability of this information to their
 particular situation.